DeutschNewstral
Article
Forbes on 2024-05-02 09:54
Ozempic Maker Novo Nordisk Beats Profit Forecasts Amid Weight Loss Drug Frenzy
Related news
- Novo Nordisk Beats Profit Forecasts As Weight-Loss Sales SoarForbes
- Weight-Loss Drug Frenzy Drives Eli Lilly And Novo Nordisk Stock To Record HighsForbes
Weight-loss drug frenzy cements Novo Nordisk as Europe's most valuable company - Fri, 13 Oct 2023 PSTsyndication.washingtonpost.com
Inside Novo Nordisk, the Company Behind Ozempic and WegovyThe New York Times- MNovo Nordisk sues pharmacies over impure Wegovy, Ozempic dupesmvtelegraph.com
- Weight-Loss Drug Wegovy Launches In U.K. As Shares Of Drugmaker Novo Nordisk Hit New PeakForbes
- MWegovy-maker Novo Nordisk extends curb on provide of weight-loss drug, raises outlookmvtelegraph.com
Growing demand for weight loss treatments drives sales at drugmaker Novo NordiskShropshire Star- Novo Nordisk Buys Hypertension Drug Ocedurenone For $1.3 Billion—Expanding Ozempic Maker’s ArsenalForbes
Sales skyrocket for weight-loss drug firm Novo Nordiskeuronews
Ozempic maker Novo Nordisk surges past Tesla with market value of $566BNew York Post- TNovo Nordisk, Eli Lilly leap as Ozempic show promise in kidney patient treatmentthestreet.com
- Bernie Sanders Urges Ozempic Maker Novo Nordisk To Be Fair Over ‘Outrageously Expensive’ U.S. Drug PricesForbes
- Here’s Why Ozempic And Mounjaro Rivals Won’t Topple Weight Loss Drugmakers Novo Nordisk And Eli Lilly Anytime SoonForbes
- MAs Ozempic/Wegovy frenzy continues, Morgan Stanley lifts forecasts for weight-loss drugs to $77 billion2 min readmarketwatch.com
- Ozempic and Wegovy, Novo Nordisk’s Weight Loss Drugs, Reshape Denmark’s EconomyThe New York Times
- INovo Nordisk results: profits grow by over 30% off the back of weight-loss brand WeGovyinvezz.com
Novo Nordisk prioritizes existing patients for weight-loss drug as demand soarsPolitico.eu- IEarnings report: Novo Nordisk cashes in on weight loss drug fever with better-than-expected resultsinvezz.com